N

Neuphoria Therapeutics Inc
NASDAQ:NEUP

Watchlist Manager
Neuphoria Therapeutics Inc
NASDAQ:NEUP
Watchlist
Price: 3.88 USD 4.02% Market Closed
Market Cap: 20.9m USD

Wall Street
Price Targets

NEUP Price Targets Summary
Neuphoria Therapeutics Inc

Wall Street analysts forecast NEUP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NEUP is 9.96 USD with a low forecast of 2.32 USD and a high forecast of 21 USD.

Lowest
Price Target
2.32 USD
40% Downside
Average
Price Target
9.96 USD
157% Upside
Highest
Price Target
21 USD
441% Upside
Neuphoria Therapeutics Inc Competitors:
Price Targets
FDMT
4D Molecular Therapeutics Inc
350% Upside
VRTX
Vertex Pharmaceuticals Inc
11% Upside
LCTX
Lineage Cell Therapeutics Inc
170% Upside
TRDA
Entrada Therapeutics Inc
64% Upside
OXB
Oxford BioMedica PLC
21% Upside
196170
Alteogen Inc
20% Upside
IMNM
Immunome Inc
63% Upside
PHIL
Philogen SpA
14% Upside

Revenue
Forecast

Revenue Estimate
Neuphoria Therapeutics Inc

For the last 5 years the compound annual growth rate for Neuphoria Therapeutics Inc's revenue is 247%.

247%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Neuphoria Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

Net Income Estimate
Neuphoria Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-83%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NEUP's stock price target?
Price Target
9.96 USD

According to Wall Street analysts, the average 1-year price target for NEUP is 9.96 USD with a low forecast of 2.32 USD and a high forecast of 21 USD.

Back to Top